These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31711480)

  • 1. Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis.
    Hanlon P; Hannigan L; Rodriguez-Perez J; Fischbacher C; Welton NJ; Dias S; Mair FS; Guthrie B; Wild S; McAllister DA
    BMC Med; 2019 Nov; 17(1):201. PubMed ID: 31711480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings.
    Smith SM; Wallace E; O'Dowd T; Fortin M
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD006560. PubMed ID: 26976529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: An individual participant data meta-analysis.
    Butterly EW; Hanlon P; Shah ASV; Hannigan LJ; McIntosh E; Lewsey J; Wild SH; Guthrie B; Mair FS; Kent DM; Dias S; Welton NJ; McAllister DA
    PLoS Med; 2023 Jan; 20(1):e1004154. PubMed ID: 36649256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study.
    Kuan V; Denaxas S; Patalay P; Nitsch D; Mathur R; Gonzalez-Izquierdo A; Sofat R; Partridge L; Roberts A; Wong ICK; Hingorani M; Chaturvedi N; Hemingway H; Hingorani AD;
    Lancet Digit Health; 2023 Jan; 5(1):e16-e27. PubMed ID: 36460578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of age, sex, and morbidity count on trial attrition: meta-analysis of individual participant level data from phase 3/4 industry funded clinical trials.
    Lees JS; Hanlon P; Butterly EW; Wild SH; Mair FS; Taylor RS; Guthrie B; Gillies K; Dias S; Welton NJ; McAllister DA
    BMJ Med; 2022; 1(1):e000217. PubMed ID: 36936559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data.
    Hanlon P; Butterly E; Shah ASV; Hannigan LJ; Wild SH; Guthrie B; Mair FS; Dias S; Welton NJ; McAllister DA
    BMC Med; 2022 Oct; 20(1):410. PubMed ID: 36303169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings.
    Smith SM; Soubhi H; Fortin M; Hudon C; O'Dowd T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006560. PubMed ID: 22513941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Rules Analysis of Comorbidity and Multimorbidity: The Concord Health and Aging in Men Project.
    Held FP; Blyth F; Gnjidic D; Hirani V; Naganathan V; Waite LM; Seibel MJ; Rollo J; Handelsman DJ; Cumming RG; Le Couteur DG
    J Gerontol A Biol Sci Med Sci; 2016 May; 71(5):625-31. PubMed ID: 26508296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimorbidity and COPD Medication Receipt Among Medicaid Beneficiaries With Newly Diagnosed COPD.
    Ajmera M; Sambamoorthi U; Metzger A; Dwibedi N; Rust G; Tworek C
    Respir Care; 2015 Nov; 60(11):1592-602. PubMed ID: 26329356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions.
    Hanlon P; Butterly E; Lewsey J; Siebert S; Mair FS; McAllister DA
    BMC Med; 2020 Oct; 18(1):309. PubMed ID: 33087107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of varying the number and selection of conditions on estimated multimorbidity prevalence: A cross-sectional study using a large, primary care population dataset.
    MacRae C; McMinn M; Mercer SW; Henderson D; McAllister DA; Ho I; Jefferson E; Morales DR; Lyons J; Lyons RA; Dibben C; Guthrie B
    PLoS Med; 2023 Apr; 20(4):e1004208. PubMed ID: 37014910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional, population-based study measuring comorbidity among people living with HIV in Ontario.
    Kendall CE; Wong J; Taljaard M; Glazier RH; Hogg W; Younger J; Manuel DG
    BMC Public Health; 2014 Feb; 14():161. PubMed ID: 24524286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic physical conditions, multimorbidity and physical activity across 46 low- and middle-income countries.
    Vancampfort D; Koyanagi A; Ward PB; Rosenbaum S; Schuch FB; Mugisha J; Richards J; Firth J; Stubbs B
    Int J Behav Nutr Phys Act; 2017 Jan; 14(1):6. PubMed ID: 28100238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights on multimorbidity and associated health service use and costs from three population-based studies of older adults in Ontario with diabetes, dementia and stroke.
    Griffith LE; Gruneir A; Fisher K; Panjwani D; Gafni A; Patterson C; Markle-Reid M; Ploeg J
    BMC Health Serv Res; 2019 May; 19(1):313. PubMed ID: 31096989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A community-based nurse-led medication self-management intervention in the improvement of medication adherence in older patients with multimorbidity: protocol for a randomised controlled trial.
    Yang C; Hui Z; Zeng D; Zhu S; Wang X; Lee DTF; Chair SY
    BMC Geriatr; 2021 Mar; 21(1):152. PubMed ID: 33653300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-drug therapy in chronic condition multimorbidity: a systematic review.
    Doos L; Roberts EO; Corp N; Kadam UT
    Fam Pract; 2014 Dec; 31(6):654-63. PubMed ID: 25192902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of multimorbidity and their association with health outcomes within Yorkshire, England: baseline results from the Yorkshire Health Study.
    Li J; Green M; Kearns B; Holding E; Smith C; Haywood A; Cooper C; Strong M; Relton C
    BMC Public Health; 2016 Jul; 16():649. PubMed ID: 27464646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conceptualizing multiple drug use in patients with comorbidity and multimorbidity: proposal for standard definitions beyond the term polypharmacy.
    Kadam UT; Roberts I; White S; Bednall R; Khunti K; Nilsson PM; Lawson CA
    J Clin Epidemiol; 2019 Feb; 106():98-107. PubMed ID: 30385327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of multimorbidity in short-term mortality of lung cancer patients in Spain: a population-based cohort study.
    Niksic M; Redondo-Sanchez D; Chang YL; Rodriguez-Barranco M; Exposito-Hernandez J; Marcos-Gragera R; Oliva-Poch E; Bosch-Barrera J; Sanchez MJ; Luque-Fernandez MA
    BMC Cancer; 2021 Sep; 21(1):1048. PubMed ID: 34556072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of multiple comorbidities on mortality in chronic obstructive pulmonary disease among Korean population: a nationwide cohort study.
    Kim Y; Kim YJ; Cho WK
    BMC Pulm Med; 2021 Feb; 21(1):56. PubMed ID: 33573635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.